Cargando…
Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease
BACKGROUND: Enteric fistula is one of the penetrating features in Crohn’s disease (CD). This study aimed to clarify the prognostic factors for the efficacy of infliximab (IFX) treatment in luminal fistulizing CD patients. METHODS: We retrospectively included 26 cases diagnosed with luminal fistulizi...
Autores principales: | Ma, Ye, Zhang, Runfeng, Liu, Wei, Sun, Yinghao, Li, Jingnan, Yang, Hong, Lv, Hong, Li, Yue, Tan, Bei, Sun, Xiyu, Qian, Jiaming, Li, Ji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997017/ https://www.ncbi.nlm.nih.gov/pubmed/36890451 http://dx.doi.org/10.1186/s12876-023-02676-9 |
Ejemplares similares
-
Optimized timing of using infliximab in perianal fistulizing Crohn's disease
por: Sun, Xue-Liang, et al.
Publicado: (2020) -
Influence of previous corticosteroid treatment on the efficacy and safety of infliximab therapy in Crohn disease
por: Liu, Ailing, et al.
Publicado: (2019) -
Evaluating the effectiveness of infliximab on perianal fistulizing Crohn’s disease by magnetic resonance imaging
por: Yan, Xiaohan, et al.
Publicado: (2019) -
Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn's disease
por: Agrawal, Gaurav, et al.
Publicado: (2015) -
Fistulizing Crohn’s Disease
por: Scharl, Michael, et al.
Publicado: (2017)